EAM
PRAH

EULAV Asset Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

EULAV Asset Management’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-15,200
Closed -$1.4M – 322
2018
Q4 		$1.4M Hold
15,200
– – 0.07% 216
2018
Q3 		$1.68M Hold
15,200
– – 0.07% 205
2018
Q2 		$1.42M Hold
15,200
– – 0.07% 215
2018
Q1 		$1.26M Hold
15,200
– – 0.06% 217
2017
Q4 		$1.38M Hold
15,200
– – 0.07% 219
2017
Q3 		$1.16M Hold
15,200
– – 0.05% 235
2017
Q2 		$1.14M Sell
15,200
-4,000
-21% -$277K 0.06% 233
2017
Q1 		$1.25M Buy
19,200
+2,600
+16% +$153K 0.06% 238
2016
Q4 		$915K Buy
16,600
+1,100
+7% +$60.4K 0.05% 245
2016
Q3 		$876K Buy
+15,500
New +$760K 0.05% 250

Other funds holding PRAH

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

EULAV Asset Management's PRAH Position: Q1 2019 in Review

EULAV Asset Management sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2019, closing a stake of 15,200 shares — an estimated $1.4M sold.

EULAV Asset Management first reported a position in PRAH in Q3 2016 and held it in 10 quarters. The position peaked at $1.68M in Q3 2018. 354 funds tracked by Wall St. Rank hold PRAH as of Q1 2019.

  • EULAV Asset Management reported no remaining PRA Health Sciences, Inc. position as of Q1 2019 after selling out during the quarter.
  • EULAV Asset Management sold 15,200 PRA Health Sciences, Inc. shares in Q1 2019, an estimated $1.4M.
  • EULAV Asset Management first reported a position in PRA Health Sciences, Inc. in Q3 2016 and held it in 10 quarters.
  • EULAV Asset Management's PRA Health Sciences, Inc. position peaked at $1.68M in Q3 2018.
  • 354 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2019.

Based on EULAV Asset Management's 13F filing for Q1 2019, filed 13 May 2019.